Advanced search
Publication Cover

Culture, Health & Sexuality

An International Journal for Research, Intervention and Care
Volume 22, 2020 - Issue 12
205
Views
6
CrossRef citations to date
0
Altmetric
Articles

Beyond clinical trials: social outcomes of structured stakeholder engagement in biomedical HIV prevention trials in China

ORCID Icon & ORCID Icon
Pages 1365-1381
Received 01 Apr 2019
Accepted 17 Oct 2019
Published online: 08 Nov 2019

Abstract

Stakeholder engagement is increasingly recognised and institutionalised as an essential component of HIV-related biomedical research. However, we know little about stakeholder engagement’s social outcomes, such as its influence on the community it engages with, in authoritarian regimes and beyond high-income countries. This study evaluates a multi-site structured stakeholder engagement programme conducted in parallel with two HIV prevention studies among men who have sex with men in China. We conducted a one-month ethnographic study and 41 semi-structured interviews with participants of a structured stakeholder engagement programme in six Chinese cities. We found that the structured stakeholder engagement programme offered community stakeholders additional and flexible funding, networking opportunities, increased clinical research literacy, and strengthened their connections with the community. However, the structured stakeholder programme generated unintended consequences in some cases. It caused community stakeholders to expend their social capital, introduced moral conflicts and created tension between stakeholders’ ‘community representative’ and ‘research assistant’ identities. Our findings suggest that despite these unintended consequences, structured stakeholder engagement could effectively mitigate negative outcomes generated by such engagement if such programmes are more sensitive and responsive to the broader socio-political structure in which trials are embedded.

Disclosure statement

No authors report any other disclosures or conflicts of interest.

Additional information

Funding

This study was supported by the Good Participatory Practices program at the Aaron Diamond AIDS Research Center. This study was supported with funding from GlaxoSmithKline. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the article. KM is also supported by a National Center for Advancing Translational Sciences, US National Institutes of Health Clinical and Translational Science Award program under Grant #UL1TR001866.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
EUR 40.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
EUR 189.00 Add to cart

Purchase access via tokens

  • Choose from packages of 10, 20, and 30 tokens
  • Can use on articles across multiple libraries & subject collections
  • Article PDFs can be downloaded & printed
From EUR 400.00
per package
Learn more
* Local tax will be added as applicable
 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.